The Propeller digital health platform consists of inhaler sensors, a patient mobile app or web portal, a clinician portal for provider monitoring as well as support and coaching. These components seamlessly integrate with one another to improve outcomes for patients and healthcare providers. Learn more about each component of our platform below.

Inhaler Sensors: Propeller's sensors attach to patients’ existing inhalers and work with the majority of inhalers on the market. This includes sensors for MDI, Respimat®, Diskus®, Ellipta® and Symbicort® medications. Sensors automatically track how often patients use their medication and send audio reminders when it’s time to take a dose. 

Respimat is a registered trademark of Boehringer Ingelheim Pharmaceuticals, Inc. Diskus and Ellipta are registered trademarks of the GlaxoSmithKline group of companies. Symbicort is a registered trademark of the AstraZeneca group of companies.

Mobile App & Web Portal: The inhaler sensors send information wirelessly to an app on the patient’s smartphone or to a web portal with their unique login. Over time, the app learns about their symptoms and medication use (including when, where and how often) and can help patients identify their triggers. In addition to monthly trend reports, the app also provides a daily outlook for patients to plan for the day (based on weather and air quality), personalized tips and education content to help them learn about and manage their condition.

Clinician Portal: Our Clinician Portal allows physicians and clinical staff to remotely monitor and view reports about patients’ rescue medication usage, adherence, symptoms and triggers as well as monthly Asthma Control Test (ACT) or COPD Assessment Test (CAT) scores. Providers can use this information to adjust treatment plans. Between visits, providers can choose to receive notifications when patients have not been compliant with controller medication or when rescue medication use increases significantly, helping them identify patients who are at a greater risk for an exacerbation. 

Patient and Provider Support: The Propeller platform also includes service and support from an international consumer experience team, such as on-call health coaching to support users through their clinical journey. From patient to provider inquiries, our support team is available to provide answers via phone, email or chat.

Propeller Health Solutions

Propeller configures its digital health platform to offer solutions that meet the specific needs of healthcare and life sciences partners in fee-for-service and value-based care settings. 

• Independent physician groups: Enabling enhanced patient care through Remote Therapeutic Monitoring (RTM) programs for eligible chronic patients
• Hospitals and health systems: Launching digital health programs in select clinics, populations or systemwide, or integrating into a service line/specialty for population health management
• Payers and pharmacy benefits managers (PBMs): Integrating digital health programs into existing care management or population health initiatives 
• Life science organizations: Integrating or co-packaging digital companion (sensor, app, support) with inhalers to support clinical trials, medication adherence, and other initiatives

At Propeller Health, our mission is to empower every person living with a chronic respiratory disease to take control of their health so they can live a better life. As a leader in digital health and therapeutics for asthma and COPD, we work to improve clinical outcomes, healthcare costs, and quality of life by supporting patients in managing their condition with their healthcare provider.  

Propeller’s platform includes FDA-cleared medical devices, consumer apps and access to clinical data for provider monitoring throughout the care journey, to create value to all stakeholders. We enable a personalized digital experience with a human touch used by patients, caregivers, providers, payers, pharmaceutical companies and other healthcare organizations across the US, Europe and Asia.

As of January 2022, Propeller has launched over 80 commercial client and clinical research programs, helping support more than 140,000 asthma and COPD patients in 27 countries with their breathing.

Propeller Health is a wholly owned subsidiary of ResMed. For more information, visit www.propellerhealth.com.

To learn about how Propeller differentiates from other options in this space, please reach out to partnerships@propellerhealth.com.

Propeller’s FDA-cleared digital health platform includes medical devices, consumer apps and access to clinical data for provider monitoring throughout the care journey. We stand apart from others in this industry because: 

- Our platform is used by a broad spectrum of patients from pediatric (asthma) to elderly (COPD), including underserved and difficult to engage populations (Medicaid, Medicare). 

- We have unique experience partnering and creating value for stakeholders across the health ecosystem: independent clinics, hospitals & health systems, payers, PBMs, pharmaceutical companies as well as patients and clinicians. 

- We have a history of delivering outcomes (quality of life, clinical, financial), essential for value based care pathways.

- Our platform engages patients with COPD earlier in their care during stages 1 and 2, while serving patients in later stages 3 and 4 through our parent company’s solutions (ResMed).

For more information on how Propeller differentiates from others in this space, please reach out to partnerships@propellerhealth.com.